Immediate Impact
14 by Nobel laureates 28 from Science/Nature 143 standout
Citing Papers
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
New and emerging targeted treatments in advanced non-small-cell lung cancer
2016 Standout
Works of Jay Gibbons being referenced
A phase I trial of X-396, a novel ALK inhibitor, in patients with advanced solid tumors.
2014
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity inPten+/−mice
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jay Gibbons | 1049 | 148 | 342 | 353 | 14 | 1.5k | |
| Marion Wiesmann | 975 | 128 | 350 | 468 | 20 | 1.5k | |
| Haluk Yuzugullu | 1341 | 163 | 300 | 530 | 12 | 1.8k | |
| Yoko Ueno | 891 | 148 | 214 | 372 | 19 | 1.3k | |
| T. Annie T. Fong | 1283 | 126 | 231 | 516 | 10 | 1.8k | |
| Sophia Abraham | 815 | 107 | 486 | 557 | 11 | 1.5k | |
| K. Peter Hirth | 1330 | 118 | 672 | 513 | 14 | 2.2k | |
| Katherine G. Moss | 1197 | 189 | 212 | 663 | 17 | 1.9k | |
| Carlos García-Echeverría | 1146 | 225 | 288 | 388 | 9 | 1.5k | |
| Jens Quant | 1128 | 171 | 554 | 725 | 15 | 2.0k | |
| Jacqueline M. Mason | 1171 | 91 | 183 | 471 | 21 | 1.6k |
All Works
Loading papers...